Roth Capital Maintains Buy on Cingulate, Lowers Price Target to $16
Benzinga Newsdesk 11 months ago
NewsPrice TargetAnalyst Ratings
Roth Capital analyst Boobalan Pachaiyappan maintains Cingulate (NASDAQ:CING) with a Buy and lowers the price target from $17 to $16.
Roth Capital analyst Boobalan Pachaiyappan maintains Cingulate (NASDAQ:CING) with a Buy and lowers the price target from $17 to $16.